202 related articles for article (PubMed ID: 6250106)
1. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
[TBL] [Abstract][Full Text] [Related]
2. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
3. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
Gralla RJ; Tyson LB; Bordin LA; Clark RA; Kelsen DP; Kris MG; Kalman LB; Groshen S
Cancer Treat Rep; 1984 Jan; 68(1):163-72. PubMed ID: 6318993
[No Abstract] [Full Text] [Related]
6. Nabilone and other antiemetics for cancer patients.
Med Lett Drugs Ther; 1988 Jan; 30(756):2-4. PubMed ID: 2826977
[No Abstract] [Full Text] [Related]
7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
8. delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Kluin-Neleman JC; Neleman FA; Meuwissen OJ; Maes RA
Vet Hum Toxicol; 1979 Oct; 21(5):338-40. PubMed ID: 516362
[TBL] [Abstract][Full Text] [Related]
9. Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
Devine ML; Dow GJ; Greenberg BR; Holstein DW; Icaza L; Jue PY; Meyers FH; O'Brien E; Roberts CM; Rocchio GL
Clin Pharm; 1987 Apr; 6(4):319-22. PubMed ID: 2822339
[No Abstract] [Full Text] [Related]
10. Antiemetics for patients treated with antitumor chemotherapy.
Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Sallan SE; Zinberg NE; Frei E
N Engl J Med; 1975 Oct; 293(16):795-7. PubMed ID: 1099449
[TBL] [Abstract][Full Text] [Related]
12. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
13. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
[TBL] [Abstract][Full Text] [Related]
14. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
15. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
[TBL] [Abstract][Full Text] [Related]
16. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
[TBL] [Abstract][Full Text] [Related]
17. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
Steele N; Gralla RJ; Braun DW; Young CW
Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
[TBL] [Abstract][Full Text] [Related]
19. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Chan HS; Correia JA; MacLeod SM
Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
[TBL] [Abstract][Full Text] [Related]
20. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
Bruera ED; Roca E; Cedaro L; Chacón R; Estévez R
Cancer Treat Rep; 1983 Apr; 67(4):381-3. PubMed ID: 6342770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
